Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment
Valerie A Flores, Lubna Pal, JoAnn E Manson
Endocrine Reviews, Volume 42, Issue 6, December 2021, Pages 720–752,
Published: 15 April 2021 Article history
DOI: https://doi.org/10.1210/endrev/bnab011
Rare Causes of Hypercalcemia: 2021 Update
Yasaman Motlaghzadeh, John P Bilezikian, Deborah E Sellmeyer
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 11, November 2021, Pages 3113–3128, Published: 08 July 2021 Article history
DOI: https://doi.org/10.1210/clinem/dgab504
Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma
Luca Giovanella, Maria Luisa Garo, Luca Ceriani, Gaetano Paone, Alfredo Campenni’, Federica D’Aurizio
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 12, December 2021, Pages 3634–3643,
DOI: https://doi.org/10.1210/clinem/dgab564
Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
Lin Y, Richardson C, Dobrin J, DeJonckheere M, Mizokami-Stout K, Fetters M et al
Diabetes Care 2022;45(3):520–528
https://doi.org/10.2337/dc21-1285
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 DiabetesThe SURPASS-5 Randomized Clinical Trial
Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H et al
JAMA. 2022;327(6):534-545.
doi:10.1001/jama.2022.0078
Comentarios recientes